- Top Workplaces
- Verastem Oncology
Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition.
Purpose
To create a world where no cancer patient ever runs out of options.
Vision
To accelerate the development of a complimentary portfolio of targeted cancer therapies.
Mission
To establish VS-6766 as the backbone therapy for RAS-driven tumors.
Additional Culture Details
Turn potential into possible
We believe that seeing potential isn’t nearly enough. Potential is an equation that must be solved, a story that must be written, and a mountain that must be climbed – not only for some but for all. That’s why we must act to connect all areas of potential to improve survival today, no matter where it originates and no matter what it takes us to get there. We’ll find what’s possible in the exciting science of cancer pathways and the power of external collaborations to accelerate our progress.
Patients fighting cancer need treatments that work for them. And they need it now. We’re committed to making that possible. We have the will and the work ethic to urgently advance our knowledge of promising, emerging mechanisms of cancer. And we have the vision to turn that science into medicines for more patients. Our ability to impact patients’ lives is often found by looking harder and deeper within complex systems that need to be explored. We will meet these challenges, and those yet to come. Moving with a sense of urgency, we’ll accelerate the pace of development and shorten the distance between recognizing potential and delivering on our purpose to ensure patients never run out of options.We seek this for our fellow human beings. For progress. For purpose.
We believe that seeing potential isn’t nearly enough. Potential is an equation that must be solved, a story that must be written, and a mountain that must be climbed – not only for some but for all. That’s why we must act to connect all areas of potential to improve survival today, no matter where it originates and no matter what it takes us to get there. We’ll find what’s possible in the exciting science of cancer pathways and the power of external collaborations to accelerate our progress.
Patients fighting cancer need treatments that work for them. And they need it now. We’re committed to making that possible. We have the will and the work ethic to urgently advance our knowledge of promising, emerging mechanisms of cancer. And we have the vision to turn that science into medicines for more patients. Our ability to impact patients’ lives is often found by looking harder and deeper within complex systems that need to be explored. We will meet these challenges, and those yet to come. Moving with a sense of urgency, we’ll accelerate the pace of development and shorten the distance between recognizing potential and delivering on our purpose to ensure patients never run out of options.We seek this for our fellow human beings. For progress. For purpose.
Values
- Purposeful
- We are purposeful, acting deliberately to positively impact patients and others. This is our focus—because this is what’s most important.
Recent Awards
2022
Company Snapshots
